Cells undergo dynamic changes in morphology or motility during cellular division and proliferation, differentiation, neuronal pathfinding, wound healing, apoptosis, host defense and organ development. These processes are controlled by signalling events relayed through cascades of protein interactions leading to the establishment and maintenance of cytoskeletal networks of microtubules and actin. Various regulators, including the Rho small GTPases (guanine nucleotide triphosphatases), serve as master switches to fine-tune the amplitude, duration as well as the integration of such circuitry responses. Rho GTPases are activated by guanine nucleotide-exchange factors and inactivated by GAPs (GTPase-activating proteins). Although normally down-regulating signalling pathways by catalysing their GTPase activity, many GAPs exist with various protein modules, the functions of which still largely remain unknown. BPGAP1 is a novel RhoGAP that co-ordinately regulates pseudopodia and cell migration through the interplay of its BNIP-2 and Cdc42GAP homology domains serving as a homophilic/heterophilic interaction device, an enzymic RhoGAP domain that inactivates RhoA and a proline-rich region that binds the Src homology-3 domain of cortactin. Both proteins co-localize to cell periphery and enhance cell migration. As a molecular scaffold in cortical actin assembly and organization, cortactin and its interaction with small GTPases, GAPs and tyrosine kinases seems set to provide further insights to the multiplicity and complexity of cell dynamics control. Elucidating how these processes might be individually or co-ordinately regulated through cortactin remains an exciting future challenge.
Introduction
Small GTPases (guanine nucleotide triphosphatases) constitute a large superfamily of molecular switches that regulate important signalling networks for cell dynamics including cell-shape changes, cell growth and differentiation, apoptosis, cell migration, intracellular trafficking and tissue/organ development [1, 2] . These pathways are activated by the exchange of their GDP for GTP, catalysed by guanine nucleotide exchange factors, but inactivated by GAPs (GTPaseactivating proteins), which in turn catalyse the hydrolysis of the GTP to GDP through their GAP domains. At least 80 distinct proteins harbouring the GAP domain are expected to be encoded by the human genome [3] . To date, there is no specific GAP for a single GTPase; instead GAPs recognize more than one member within a GTPase subfamily, and a single GTPase can be the target of multiple GAPs, sometimes with varying substrate profiles in vitro and in vivo. Given the potency of GTPases and the requirement for an intricate and balanced control, it is evident that more and more GAPs are required to play key roles in many facets of cell dynamics control (Table 1) . Although GAPs usually function to turn off GTPase signalling, some are believed to function as effectors, e.g. the RasGAP neurofibromatosis 1 [4] and TcGAP for insulin-stimulated glucose transport [5] , or to potentiate the action of the protein they reside in, e.g increasing the activity for the regulatory subunits of phosphoinositide 3-kinase [6] . Since many GAPs also contain multiple-signalling modules linked to pathways of tyrosine kinases, phosphoinositides and serine-threonine kinases, they are poised to co-ordinate numerous molecules to converge or diverge signals inside cells. All this evidence points to the complexity and pleiotropic modes of cross-regulation among GTPases, GAPs and other potential signalling partners, highlighting the need to address the functions of GAPs in totality, including the roles of other domains they carry and how they influence the function of GAPs in space and time.
BPGAP1 as a novel integrator of cortactin and GTPase signalling
Among various subfamilies of small GTPases, Rho family members (with well-characterized members such as RhoA, Cdc42, and Rac) serve to fine-tune many aspects of cell dynamics by impacting actin and microtubule-based cytoskeletal network leading to distinctive features in morphology, [37] polarity and motility of cells [7] . We recently cloned and identified a novel RhoGAP, BPGAP1, that harbours three distinct protein domains, the BCH (BNIP-2 and Cdc42GAP Homology) domain that serves as a novel homophilic and heterophilic protein interaction domain [8] [9] [10] , a PRR (proline-rich region) and a functional RhoGAP domain [11] . BPGAP1 induces the formation of pseudopodia at the cell periphery mediated by its BCH and GAP domains by involving active Cdc42 and Rac1, but inactive RhoA. Furthermore, these two domains collaborate with the PRR to bring about further the enhanced cell motility in epithelial cells. These results suggest that changes in cell morphology are coupled with determinant(s) of cell migration. To elucidate the molecular mechanism underlying BPGAP1-induced cell dynamics, we employed protein precipitation and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry [12] and identified cortactin, a cortical actin-binding protein, as a novel partner of BPGAP1 [13] . Being a multidomain protein itself, cortactin acts as an adaptor or scaffold by interacting with various signalling partners in different cell types and locations [14, 15] . Our in vitro and in vivo protein interaction studies confirmed that cortactin indeed interacts directly and specifically with BPGAP1 in a constitutive manner that requires its SH3 (where SH stands for Src homology) domain binding to the proline-rich motif of BPGAP1, 182-PPPRPPLP-189, with both prolines 184 and 186 being indispensable for their interaction. This target sequence differs from the consensus binding site (+PPψPxKP) (where + and ψ indicate basic Cortactin regulates cell migration through multiple mechanisms, for example, by BPGAP1 facilitating its translocation and pseudopodia formation [13] , alternative splicing variants lacking the certain repeats in F-actin-binding domain [21] , on phosphorylation by Fyn or Src after integrin and receptor tyrosine kinase activation [39] or overexpression by gene amplifications in tumours [40] .
and hydrophobic amino acid residues respectively) for many partners of cortactin SH3 domain [16] highlighting the uniqueness for functional coupling. To date, no RhoGAP has been implicated in any of the cortactin-mediated signalling, although both have been widely studied for their separate cellular processes. BPGAP1 functions as a RhoA inactivator through its GAP domain while causing cell extensions through its BCH and GAP domains in a process that requires both active Cdc42 and Rac1 [11] . Intriguingly, the BCH domain of BPGAP1, in addition to its ability to form homophilic and heterophilic complex, also interacts selectively with Cdc42. Cortactin has been shown to be involved in Rac1-and Cdc42-dependent pathways [17, 18] that promote the Arp2/Arp3 activity necessary for protrusive-based cell motility, whereas Rac1 is required for the translocation of cortactin to the membrane periphery [18] . Since cortactin itself is not directly associated with these GTPases, BPGAP1 could, therefore, serve as the molecular link to these proteins, and represent one of the mechanisms underlying cortactin effects on cell migration (Figure 1 ).
BPGAP1 modulates cortactin and actin disposition in cells
Cortactin is normally distributed diffusely in the cytoplasm of quiescent cells and upon overexpression or cell stimulation, it is translocated to the periphery [19] [20] [21] . Overexpressed BPGAP1 and endogenous cortactin mainly co-localize within cytoplasm, and also on the membrane periphery along with the filamentous actin. Cells without BPGAP1 overexpression show a clear loss of cortactin as well as decreased actin disposition on the membrane periphery, whereas a BPGAP1 mutant that does not interact with cortactin fails to display the presence of cortactin and actin on the membrane periphery or the protruding ends, despite the mutant being localized to those areas [13] . Consequently, co-expression of BPGAP1 and cortactin in a complex, but not alone or as non-interacting mutants, promotes a significant increase in epithelial cell migration. These results strongly suggest that the binding of BPGAP1 to cortactin facilitates the translocation of cortactin and the assembly of actin to the cell periphery, which then leads to enhanced cell motility.
Future prospects
BPGAP1 is the first RhoGAP that functionally interacts with cortactin and represents a novel determinant in the regulation of cell migration. Coupled with the role of BCH and GAP domains in pseudopodia formation, identification of cortactin as the link for its induced cell migration would immediately implicate that BPGAP1 could serve to bridge cortactin and GTPase signalling in the concerted regulation of cell dynamics. The intricate nature of such regulation is now being investigated. Further challenges lie on how the PRR of BPGAP1 and the SH3 domain of cortactin could distinguish different partners for functional (un)coupling at specific times and places. These include, for example, Shank proteins that organize the clustering of receptor complexes within neuronal post-synaptic sites, dynamin 2 that regulates receptor-mediated endocytosis at the membrane periphery and ZO-1 that controls tight junction assembly of epithelial cells. We believe that this issue can be resolved partly by examining the specificity of binding motifs, localization/targeting mechanism in the context of different cell types and physiological environments. Identifying other cellular components in this BPGAP1-cortactin complex or complexes in which these two proteins exist as mutually exclusive entities will remain an exciting prospect.
